| Full text | |
| Author(s): |
Natália Bonissi Gonçalves
[1]
;
Rafael Ferraz Bannitz
[2]
;
Bruna Ramos Silva
[3]
;
Danielle Duran Becari
[4]
;
Carolina Poloni
[5]
;
Patrícia Moreira Gomes
[6]
;
Milton Cesar Foss
[7]
;
Maria Cristina Foss-Freitas
[8]
Total Authors: 8
|
| Affiliation: | [1] Universidade de Sao Paulo. Divisao de Endocrinologia e Metabolismo, Faculdade de Medicina de Ribeirao Preto. Departamento de Medicina - Brasil
[2] Universidade de Sao Paulo. Divisao de Endocrinologia e Metabolismo, Faculdade de Medicina de Ribeirao Preto. Departamento de Medicina - Brasil
[3] Universidade de Sao Paulo. Divisao de Endocrinologia e Metabolismo, Faculdade de Medicina de Ribeirao Preto. Departamento de Medicina - Brasil
[4] Universidade de Sao Paulo. Divisao de Endocrinologia e Metabolismo, Faculdade de Medicina de Ribeirao Preto. Departamento de Medicina - Brasil
[5] Universidade de Sao Paulo. Divisao de Endocrinologia e Metabolismo, Faculdade de Medicina de Ribeirao Preto. Departamento de Medicina - Brasil
[6] Universidade de Sao Paulo. Divisao de Endocrinologia e Metabolismo, Faculdade de Medicina de Ribeirao Preto. Departamento de Medicina - Brasil
[7] Universidade de Sao Paulo. Divisao de Endocrinologia e Metabolismo, Faculdade de Medicina de Ribeirao Preto. Departamento de Medicina - Brasil
[8] Universidade de Sao Paulo. Divisao de Endocrinologia e Metabolismo, Faculdade de Medicina de Ribeirao Preto. Departamento de Medicina - Brasil
Total Affiliations: 8
|
| Document type: | Journal article |
| Source: | Clinics; v. 73, 2018-10-29. |
| Abstract | |
OBJECTIVES: Dietary omega-3 fatty acids have been efficacious in decreasing serum cholesterol levels and reducing the risk of cardiovascular disease. However, the metabolic and molecular changes induced by the omega-3 fatty acid α-linolenic acid (ALA), which is found in linseed oil, are not fully understood. In this study, we showed a correlation between ALA and insulin resistance, inflammation and endoplasmic reticulum stress (ERS). METHODS: We studied 40 male mice (C57/BL6) divided into 4 groups: a control (C) group, a control + omega-3/ALA (CA) group, a high-fat diet (HFD) (H) group and a high-fat diet + omega-3/ALA (HA) group. For 8 weeks, the animals in the H and HA groups were fed a high-fat (60%) diet, while the animals in the C and CA groups received regular chow. The diets of the CA and HA groups were supplemented with 10% lyophilized ALA. RESULTS: ALA supplementation improved glucose tolerance and reduced insulin resistance, as measured by intraperitoneal glucose tolerance tests and the homeostasis model assessment for insulin resistance, respectively. In addition, ALA reduced hepatic steatosis and modified the standard fat concentration in the liver of animals fed an HFD. Dietary ALA supplementation reduced the serum levels of interleukin 6 (IL-6), interleukin 1 beta (IL-1β) and monocyte chemoattractant protein-1 (MCP-1), increased the expression of important chaperones such as binding immunoglobulin protein (BIP) and heat shock protein 70 (HSP70) and reduced the expression of C/EBP-homologous protein (CHOP) and X-box binding protein 1 (XBP1) in hepatic tissues, suggesting an ERS adaptation in response to ALA supplementation. CONCLUSIONS: Dietary ALA supplementation is effective in preventing hepatic steatosis; is associated with a reduction in insulin resistance, inflammation and ERS; and represents an alternative for improving liver function and obtaining metabolic benefits. (AU) | |
| FAPESP's process: | 11/09640-7 - Metabolic effects of omega-3 fatty acid in insulin resistance conditions |
| Grantee: | Maria Cristina Foss de Freitas |
| Support Opportunities: | Research Grants - Young Investigators Grants |